Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

Author： Catapano Alberico   Brady William E.   King Thomas R.   Palmisano Joanne  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.7, 2005-07, pp. : 1123-1130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

By Catapano Alberico L.   Davidson Michael H.   Ballantyne Christie M.   Brady William E.   Gazzara Russell A.   Tomassini Joanne E.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2041-2053

Informa Healthcare

Access to resources Recommend Favorite

Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis

By Ose Leiv   Shah Arvind   Davies Michael J.   Rotonda Jennifer   Maccubbin Darbie   Tribble Diane   Veltri Enrico   Mitchel Yale  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 823-835

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease

By Blagden M. D.   Chipperfield R.  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite

The efficacy of tadalafil in improving sexual satisfication and overall satisfication in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials

By Rosen Raymond C.   Shabsigh Ridwan   Kuritzky Louis   Wang Wei Christine   Sides Gregory D.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1701-1709

Informa Healthcare

Access to resources Recommend Favorite

Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia

By Bays Harold   Sapre Aditi   Taggart William   Liu Ji   Capece Rachel   Tershakovec Andrew  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2953-2966

Informa Healthcare

Access to resources Recommend Favorite